Cell Therapeutics (CTIC)
Cell Therapeutics Fundamental Score
View CTIC Fundamental Score with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
CTIC Fundamental Score Range, Past 5 Years
| Minimum | 2.00 | Dec 2010 |
| Maximum | 5.00 | Sep 2008 |
| Average | 3.833 |
About Fundamental Score
The fundamental score is YCharts proprietary score of how strong a company's fundamentals are. It ranges from 1 to 10, with 10 being the strongest. The ten tests are as follows (score one point for each test the company passes):
1) EPS Growth > 0
2) Revenue Growth > 0
3) Five Year Average ROE > 5%
4) 10 Year Minimum Gross Margin > 0
5) Book Value Per Share Growth > 0
6) Current Ratio > 1
7) Debt to Equity Ratio < 13
8) 10 Year Average Cash Flow > 0
9) Long Term Debt < 5 x Net Income
10) Uninterrupted dividend payments as far back as we have data
(unless otherwise noted, growth rates are calculated for 10 years or the life of the stock, whichever is shorter)
Further details can be found in our support center article about the fundamental score.
Learn More
You may also be interested in these CTIC related companies
CTIC News
May 11, 9:14AM Street Insider
Apr 20, 1:30AM PR Newswire
Apr 19, 8:00PM PR Newswire
Apr 19, 6:54AM Street Insider
Apr 18, 8:00PM PR Newswire
Mar 22, 8:20AM Marketwire
Mar 12, 8:20AM Marketwire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CTIC | 0.91 | -0.01 | -1.09% | 206.22M |
| CTHR | 3.89 | +0.03 | +0.78% | 75.66M |
| CTGX | 12.45 | +0.16 | +1.30% | 230.70M |
| CTFO | 4.55 | -0.09 | -1.94% | 114.98M |
| CTEL | 10.58 | -0.19 | -1.76% | 408.92M |
| CTCT | 20.58 | +0.12 | +0.59% | 622.13M |
| CTCM | 9.35 | -0.10 | -1.06% | 1.471B |
| CTB | 15.21 | -0.25 | -1.62% | 947.58M |
| CTAS | 37.31 | -0.41 | -1.09% | 4.840B |
| CSU | 9.67 | +0.12 | +1.26% | 272.11M |
